Paul Bisaro is Director of TherapeuticsMD, Inc.. Currently has a direct ownership of 5,922 shares of TXMD, which is worth approximately $6,454. The most recent transaction as insider was on Aug 18, 2022, when has been sold 1,984 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.92K
0% 3M change
0% 12M change
Total Value Held $6,454

PAUL BISARO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
1,984 Added 25.09%
5,922 Common Stock
Aug 16 2021
BUY
Open market or private purchase
$39,500 $0.79 p/Share
50,000 Added 20.25%
196,864 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
-
96,864 Added 39.74%
146,864 Common Stock

Also insider at

ZTS
Zoetis Inc. Healthcare
MNKPF
Mallinckrodt plc Healthcare
MYGN
MYRIAD GENETICS INC Healthcare
PB

Paul Bisaro

Director
Hazelwood, MO

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Track Activities on TXMD